Jacobs Levy Equity Management, Inc Sutro Biopharma, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$24.7 Billion
Q3 2024

A detailed history of Jacobs Levy Equity Management, Inc transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 821,746 shares of STRO stock, worth $2.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

821,746

Previous 1,050,189 21.75%

Holding current value

$2.84 Million

Previous $3.08 Million 7.6%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.88 - $5.01 $657,915 - $1.14 Million	-228,443 Reduced 21.75%	821,746 $2.84 Million
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $56,452 - $103,044	-19,333 Reduced 1.81%	1,050,189 $3.08 Million
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $2.38 Million - $4.12 Million	729,239 Added 214.3%	1,069,522 $6.04 Million
Q4 2023 Feb 14, 2024	SELL	$2.07 - $4.54 $176,794 - $387,752	-85,408 Reduced 20.06%	340,283 $1.46 Million
Q3 2023 Nov 16, 2023	SELL	$3.29 - $4.9 $479,359 - $713,939	-145,702 Reduced 25.5%	425,691 $1.48 Million
Q2 2023 Aug 14, 2023	SELL	$4.25 - $5.88 $396,134 - $548,063	-93,208 Reduced 14.02%	571,393 $2.66 Million
Q1 2023 May 15, 2023	SELL	$4.48 - $8.45 $12,880 - $24,293	-2,875 Reduced 0.43%	664,601 $3.07 Million
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $409,818 - $612,076	-75,752 Reduced 10.19%	667,476 $5.39 Million
Q3 2022 Nov 15, 2022	SELL	$5.17 - $7.11 $1.42 Million - $1.95 Million	-273,806 Reduced 26.92%	743,228 $4.13 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $1.35 Million - $3.55 Million	396,554 Added 63.91%	1,017,034 $5.3 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $4.83 Million - $9.5 Million	620,480 New	620,480 $5.1 Million
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $1.92 Million - $2.54 Million	-106,581 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$20.29 - $27.54 $1.03 Million - $1.4 Million	-50,720 Reduced 32.24%	106,581 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$10.16 - $23.98 $1.06 Million - $2.5 Million	104,288 Added 196.72%	157,301 $3.42 Million
Q3 2020 Nov 16, 2020	SELL	$7.44 - $13.15 $72,272 - $127,739	-9,714 Reduced 15.49%	53,013 $533,000
Q2 2020 Aug 17, 2020	SELL	$7.24 - $11.05 $20,300 - $30,984	-2,804 Reduced 4.28%	62,727 $487,000
Q1 2020 May 15, 2020	BUY	$6.19 - $12.16 $1,219 - $2,395	197 Added 0.3%	65,531 $668,000
Q4 2019 Feb 14, 2020	BUY	$8.15 - $11.39 $281,566 - $393,501	34,548 Added 112.22%	65,334 $719,000
Q3 2019 Nov 14, 2019	SELL	$7.91 - $11.76 $99,515 - $147,952	-12,581 Reduced 29.01%	30,786 $280,000
Q2 2019 Aug 13, 2019	SELL	$9.69 - $12.23 $1,540 - $1,944	-159 Reduced 0.37%	43,367 $494,000
Q1 2019 May 14, 2019	BUY	$8.8 - $11.87 $383,028 - $516,653	43,526 New	43,526 $496,000

Others Institutions Holding STRO

# of Institutions

135

Shares Held

62.1M

Call Options Held

77.1K

Put Options Held

31.4K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $180M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account

Jacobs Levy Equity Management, Inc Sutro Biopharma, Inc. Transaction History